<DOC>
	<DOCNO>NCT01050166</DOCNO>
	<brief_summary>The purpose study determine whether human islet label iron contrast agent could image use magnetic resonance transplantation liver Type 1 diabetic recipient .</brief_summary>
	<brief_title>MRI Imaging Labeled Human Islets Transplanted Into Liver</brief_title>
	<detailed_description>Islet transplantation represent approve therapeutic approach select Type 1 diabetic recipient syndrome hypoglycaemia unawareness . Existing image method sufficient provide adequate information amount fate islet transplant liver . Labeling islet superparamagnetic contrast agent ferucarbotran significantly shorten T2 relax time therefore increase contrast islet liver tissue magnetic resonance imaging . In consequence , islet transplant liver could easily detectable like hypotensive area disperse throughout liver . MRI examination do 1 , 2 , 4 week 3 , 6 12 month .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<criteria>Type 1 diabetes mellitus normal renal parameter hypoglycaemia unawareness rapid progression diabetic retinopathy neuropathy acute chronic liver disease malignancy acute infection serious cardiovascular disease coagulopathy portal hypertension presence metal protesis , cardiostimulators , metal material body</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>islet transplantation</keyword>
	<keyword>magnetic resonance</keyword>
	<keyword>Type 1 DM</keyword>
</DOC>